<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03420248</url>
  </required_header>
  <id_info>
    <org_study_id>4-2016-1108</org_study_id>
    <nct_id>NCT03420248</nct_id>
  </id_info>
  <brief_title>Comparison of Pain of Two Different Methods in Uterine Artery Embolization</brief_title>
  <official_title>Comparison of Pain After Uterine Artery Embolization Using Non-spherical Polyvinyl Alcohol Particles or Tris-acryl Gelatin Microsphere in Patients With Symptomatic Fibroids</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Severance Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Severance Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of this study is to compare pain after uterine artery embolization using
      non-spherical polyvinyl alcohol particles or tris-acryl gelatin microsphere in patients with
      symptomatic fibroids
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Uterine artery embolization(UAE) is a minimally invasive treatment alternative to
      hysterectomy and myomectomy in symptomatic fibroids. However, post-procedural pain after UAE
      remains a major problem. The non-spherical polyvinyl alcohol particle and tri-acryl gelatin
      microsphere are two embolic materials used for UAE.Therefore, the aim of study is to compare
      pain intensity and inflammation after uterine artery embolization using non-spherical
      polyvinyl alcohol particles or tris-acryl gelatin microsphere in patients with symptomatic
      fibroids
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 19, 2018</start_date>
  <completion_date type="Anticipated">April 2020</completion_date>
  <primary_completion_date type="Anticipated">March 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain intensity by numerical rating scale</measure>
    <time_frame>0-24 h after UAE</time_frame>
    <description>0-10 numerical rating scale (0, no pain at all; 10, worst pain imaginable</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>C-reactive protein</measure>
    <time_frame>24 h after UAE</time_frame>
    <description>mg/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>White blood cell count</measure>
    <time_frame>24 h after UAE</time_frame>
    <description>/uL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neutrophil percentage</measure>
    <time_frame>24 h after UAE</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neutrophil-to-lymphocyte ratio</measure>
    <time_frame>24 h after UAE</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Platelet-to-lymphocyte ratio</measure>
    <time_frame>24 h after UAE</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean platelet volume</measure>
    <time_frame>24 h after UAE</time_frame>
    <description>fL(femtolitre)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sucessful rate at 3 month after UAE measured by MRI</measure>
    <time_frame>3 month after UAE</time_frame>
    <description>Complete necrosis incidence</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">54</enrollment>
  <condition>Leiomyoma</condition>
  <arm_group>
    <arm_group_label>Non-spherical polyvinyl alcohol particle</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>For embolic material, non-spherical polyvinyl alcohol particle is used.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tris-acryl gelatin microsphere</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>For embolic material, Tris-acryl gelatin microsphere is used.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Non-spherical polyvinyl alcohol particle or Tris-acryl gelatin microsphere</intervention_name>
    <description>One of non-spherical polyvinyl alcohol particle or tris-acryl gelatin microsphere is used for embolic materials. All other processes are same.</description>
    <arm_group_label>Non-spherical polyvinyl alcohol particle</arm_group_label>
    <arm_group_label>Tris-acryl gelatin microsphere</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Uterine artery embolization due to multiple fibroids

        Exclusion Criteria:

          -  Severe liver or kidney dysfunction

          -  Drug allergy

          -  Bradycardia (&lt;45 bpm) or heart block

          -  Uncontrolled hypertension
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>So Yeon Kim, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Severance Hospital, Yonsei University College of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Man Deuk Kim, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Radiology, Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>So Yeon Kim, MD, PhD</last_name>
    <phone>82-2-227-4470</phone>
    <email>KIMSY326@yuhs.ac</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Man Deuk Kim, MD, PhD</last_name>
    <email>MDKIM@yuhs.ac</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sesverance Hospital, Yonsei University College of Medicine</name>
      <address>
        <city>Seoul</city>
        <zip>03722</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>So Yeon Kim, MD, PhD</last_name>
      <email>KIMSY326@yuhs.ac</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 16, 2018</study_first_submitted>
  <study_first_submitted_qc>January 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 2, 2018</study_first_posted>
  <last_update_submitted>May 15, 2018</last_update_submitted>
  <last_update_submitted_qc>May 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Severance Hospital</investigator_affiliation>
    <investigator_full_name>So Yeon Kim</investigator_full_name>
    <investigator_title>Assistant professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leiomyoma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethanol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

